ArticleRespirology case reports2023
Successful baricitinib treatment of refractory anti-synthetase syndrome associated with interstitial lung disease.
Keishi Sugino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it